Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

4519

Rank in Stocks #353
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Share Price
$41.34
Market Cap
$68.04B
Change (1 day)
0.05%
Change (1 year)
-12.50%
Country
JP
Trade Chugai Pharmaceutical Co., Ltd. (4519)

Category

Healthcare
Stock split history for Chugai Pharmaceutical Co., Ltd. (4519)
Chugai Pharmaceutical Co., Ltd. stock (symbol: 4519) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One 4519 share bought prior to Oct 20, 2026 would equal to 0 4519 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
4 x15
US
7 x432
US
0 -
US
7 x226
US
2 x10000
CH